MAPT and Alzheimer disease: Tau-related pathology and neurodegeneration at the molecular level may be sufficient to disrupt key brain networks, which could give the symptoms in the absence of overt brain atrophy in minimal-atrophy AD.21 The finding of reduced metabolism in the parietal cortex in minimal atrophy AD24 supports the explanation regarding network disruption.